Munich

October 21, 2023

Munich # BEE: B-cell engineering & enhancement # Our project focuses on a novel synthetic biology concept of B-cell engineering. We are genetically engineering B-cells to produce a specific antibody with the aim of using these cells as living and evolving drugs in cell therapy. Our goal is to address the epidemic of neurodegenerative diseases, particularly Alzheimer’s, to protect high-risk patients from multi-resistant pathogens, to tackle chronic viral diseases, such as MRSA and hepatitis B virus, and to combat malignant tumors, such as renal cell carcinoma. ...